Sign In
Buy NAUT
$2.58
-0.100 (-3.73%)
At Close: Jun 03, 2026
26,324 Shares in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Purchased by Squarepoint Ops LLC
03:34am, Wednesday, 11'th Jun 2025
Squarepoint Ops LLC acquired a new position in shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) in the fourth quarter, according to the company in its most recent 13F filing wi
Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call Transcript
01:01pm, Tuesday, 29'th Apr 2025
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Company Participants Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Execut
Nautilus: Trading Below An Albeit Lower Net Cash Figure
06:59pm, Friday, 28'th Feb 2025
Nautilus Biotechnology, Inc. faces reflexivity risks and macroeconomic challenges, but its commercial plan starts next year with substantial cash reserves. Trading below cash value, Nautilus' patents
Nautilus Biotechnology, Inc. (NAUT) Q4 2024 Earnings Call Transcript
07:25am, Friday, 28'th Feb 2025
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Exe
Dr. Mallick to be inducted into the Academy for Radiology and Biomedical Imaging Research's esteemed Council of Distinguished Investigators for his outstanding contributions to medical imaging Dr. Mal
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
08:00am, Wednesday, 30'th Oct 2024
SEATTLE, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company
Nautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call Transcript
01:17pm, Tuesday, 29'th Oct 2024
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q3 2024 Earnings Conference Call October 29, 2024 8:30 AM ET Company Participants Ji-Yon Yi - Investor Relations Sujal Patel - Co-Founder and Chief Executiv
Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript
03:16pm, Tuesday, 30'th Jul 2024
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q2 2024 Earnings Conference Call July 30, 2024 8:30 AM ET Company Participants Ji-Yon Yi - Investor Relations Sujal Patel - Co-Founder & Chief Executive Off
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
08:00am, Tuesday, 30'th Jul 2024
SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial r
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
08:00am, Tuesday, 09'th Jul 2024
SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will rep
Nautilus Biotechnology (NAUT) Upgraded to Buy: Here's What You Should Know
01:01pm, Friday, 03'rd May 2024
Nautilus Biotechnology (NAUT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript
01:19pm, Tuesday, 30'th Apr 2024
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q1 2024 Earnings Conference Call April 30, 2024 8:30 AM ET Company Participants Sujal Patel - Co-Founder & Chief Executive Officer Parag Mallick - Co-Founde
Nautilus Biotechnology Reports First Quarter 2024 Financial Results
08:00am, Tuesday, 30'th Apr 2024
SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
08:00am, Thursday, 11'th Apr 2024
SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will re
Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript
01:13pm, Wednesday, 28'th Feb 2024
Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript
